Connect Biopharma Holdings Limited
CNTB
$2.65
-$0.01-0.38%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -17.20M | -12.90M | -10.27M | -11.64M | -12.88M |
| Total Depreciation and Amortization | 179.00K | 171.00K | 173.00K | 92.00K | 176.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 747.00K | 663.00K | 727.00K | 2.53M | 2.03M |
| Change in Net Operating Assets | -1.13M | -526.00K | -587.00K | 1.20M | -2.34M |
| Cash from Operations | -17.41M | -12.59M | -9.96M | -7.82M | -13.01M |
| Capital Expenditure | -34.00K | -303.00K | -81.00K | -157.00K | -147.00K |
| Sale of Property, Plant, and Equipment | 0.00 | 0.00 | 2.00K | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 14.38M | 5.43M | -20.56M | -7.71M | 0.00 |
| Cash from Investing | 14.35M | 5.13M | -20.64M | -7.86M | -147.00K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | 74.00K | -- |
| Issuance of Common Stock | 215.00K | 161.00K | 2.00K | 62.50K | 0.00 |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 215.00K | 161.00K | 2.00K | 136.50K | 0.00 |
| Foreign Exchange rate Adjustments | 58.00K | 224.00K | 75.00K | -252.50K | 507.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -2.79M | -7.08M | -30.52M | -15.80M | -12.65M |